Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
38
Number of overlapping holdings
11.8%
% of FHLC's 349 holdings also in XPH
92.7%
% of XPH's 41 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 6.4% | 3.7% | 3.7% |
|
ELI LILLY & CO | 11.3% | 3.7% | 3.7% |
|
MERCK & CO. INC. | 3.8% | 3.5% | 3.5% |
|
PFIZER INC | 2.4% | 3.6% | 2.4% |
|
BRISTOL-MYERS SQUIBB CO | 2.0% | 3.7% | 2.0% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to XPH
|
ELI LILLY & CO | 7.5% |
|
UNITEDHEALTH GROUP INC | 7.3% |
|
ABBVIE INC | 6.1% |
|
ABBOTT LABORATORIES | 3.8% |
|
THERMO FISHER SCIENTIFIC INC | 3.3% |
|
INTUITIVE SURGICAL INC | 3.0% |
|
AMGEN INC | 2.8% |
|
JOHNSON & JOHNSON | 2.7% |
|
GILEAD SCIENCES INC | 2.3% |
|
BOSTON SCIENTIFIC CORP | 2.3% |
FHLC Underweight Relative to XPH
|
TARSUS PHARMACEUTICALS, INC. | -3.9% |
 |
PERRIGO CO | -3.7% |
|
ELANCO ANIMAL HEALTH, INC. | -3.6% |
|
AXSOME THERAPEUTICS, INC. | -3.6% |
|
CORCEPT THERAPEUTICS INC | -3.6% |
|
ORGANON & CO. | -3.5% |
|
INTRA-CELLULAR THERAPIES INC | -3.5% |
|
PRESTIGE BRANDS HOLDINGS INC | -3.5% |
|
ROYALTY PHARMA PLC CLASS A | -3.3% |
|
VIATRIS, INC. | -3.3% |